nach oben

Current Infectious Disease Reports

Erschienen in:

01.02.2014 | Respiratory Infections (F Arnold, Section Editor)

Quality Improvement in Hospital Management of Community-Acquired Pneumonia: Focus on New Strategies and Current Challenges

verfasst von: Elizabeth A. Richey, Lauren Dudley, Stephen K. Liu

Erschienen in: Current Infectious Disease Reports | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Community-acquired pneumonia is a common reason for hospitalization and leads to significant morbidity and mortality. There are published evidence-based guidelines for the diagnosis, treatment, and management of community-acquired pneumonia. Many countries, including the US, have developed national, publically reported quality measures related to the treatment of community-acquired pneumonia. This review highlights recent published innovations aimed at improving the quality of care for patients hospitalized for community-acquired pneumonia. Interventions include standardized protocols and pathways, education and feedback from antimicrobial stewardship teams, and automated pharmacy technology. The importance of multidisciplinary collaboration and multidimensional interventions are discussed. Insight into local context and institutional support are essential to understanding the implementation of improvement efforts and these factors should be reported in future publications related to quality improvement.

National Center for Health Statistics. CDC/NCHS National Hospital Discharge Survey, 2010. Hyattsville, MD: Public Health Service; 2010.

Hoyert DL, Xu JQ. Deaths: preliminary data for 2011. National vital statistics reports. Hyattsville, MD: National Center for Health Statistics; 2012.

Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642–50.PubMedCrossRef

4.•

Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):S27–72. Most recently updated version of the IDSA/ATS consensus guidelines for community-acquired pneumonia management, which provides a number of quality improvement targets.PubMedCrossRef

Centers for Medicare & Medicaid Services. QualityNet Specifications Manual Version 4.3a: Discharges 01/01/14 to 09/30/14. Last updated 3 Oct 2013. http://www.qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%2FPage%2FQnetTier4&cid=1228773564870. Accessed 17 Jan 2014.

Program M. Hospital Inpatient Value-Based Purchasing Program; Final Rule. Fed Regist. 2011;76(88):26490–547.

Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch –Intern Med. 2008;168(4):351–6.PubMedCrossRef

Yahav D, Leibovici L, Goldberg E, Bishara J, Paul M. Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia. Int J Antimicrob Agents. 2013;41(5):410–3.PubMedCrossRef

9.•

Georges H, Journaux C, Devos P, Alfandari S, Delannoy PY, Meybeck A, et al. Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumonia. BMC Infect Dis. 2013;13:196. This single-center study highlights the success and improved outomes associated many changes in the management of severe CAP care over the last decade.PubMedCentralPubMedCrossRef

10.

Hurst JM, Bosso JA. Antimicrobial stewardship in the management of community-acquired pneumonia. Curr Opin Infect Dis. 2013;26(2):184–8.PubMed

11.

Moehring RW, Anderson DJ. Antimicrobial stewardship as part of the infection prevention effort. Curr Infect Dis Rep. 2012;14(6):592–600.PubMedCrossRef

12.

Nussenblatt V, Avdic E, Cosgrove S. What is the role of antimicrobial stewardship in improving outcomes of patients with CAP? Infect Dis Clin North Am. 2013;27(1):211–28.PubMedCrossRef

13.

Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53 Suppl 1:S23–8. quiz S29–S30.PubMedCrossRef

14.•

Avdic E, Cushinotto LA, Hughes AH, Hansen AR, Efird LE, Bartlett JG, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis. 2012;54(11):1581–7. Single-center study which leveraged an existing antimicrobial stewardship team to reduce duration of antibiotic therapy for CAP.PubMedCrossRef

15.

Afshar N, Tabas J, Afshar K, Silbergleit R. Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review. J Hosp Med. 2009;4(2):112–23.PubMedCrossRef

16.•

Sikka R, Sweis R, Kaucky C, Kulstad E. Automated dispensing cabinet alert improves compliance with obtaining blood cultures before antibiotic administration for patients admitted with pneumonia. Jt Comm J Qual Patient Saf. 2012;38(5):224–8. An example of using automated pharmacy technology to improve compliance with national quality metrics.PubMed

17.••

Ostrowsky B, Sharma S, DeFino M, Guo Y, Shah P, McAllen S, et al. Antimicrobial stewardship and automated pharmacy technology improve antibiotic appropriateness for community-acquired pneumonia. Infect Control Hosp Epidemiol. 2013;34(6):566–72. Multicampus study of a successful quality improvement intervention, which aslo provides an exemplary description of the local and institutional context, and its role in achieving change.PubMedCrossRef

18.

Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283(6):749–55.PubMedCrossRef

19.

Every NR, Hochman J, Becker R, Kopecky S, Cannon CP. Critical pathways: a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association. Circulation. 2000;101(4):461–5.PubMedCrossRef

20.

Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995;123(12):941–8.PubMedCrossRef

21.•

Carratala J, Garcia-Vidal C, Ortega L, Fernandez-Sabe N, Clemente M, Albero G, et al. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial. Arch Intern Med. 2012;172(12):922–8. This paper describes a succesful intervention using a critical pathway at two urban hopsitals.PubMedCrossRef

22.

Sharpe BA. Putting a critical pathway into practice: the devil is in the implementation details. Arch Intern Med. 2012;172(12):928–9.PubMedCrossRef

23.

Tripp DG. Did an acute medical assessment unit improve the initial assessment and treatment of community acquired pneumonia – a retrospective audit. N Z Med J. 2012;125(1354):60–7.PubMed

24.

Bosk CL, Dixon-Woods M, Goeschel CA, Pronovost PJ. Reality check for checklists. Lancet. 2009;374(9688):444–5.PubMedCrossRef

25.

Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. New Engl J Med. 2006;355(26):2725–32.PubMedCrossRef

26.

Ogrinc G, Mooney SE, Estrada C, Foster T, Goldmann D, Hall LW, et al. The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care. 2008;17 Suppl 1:i13–32. doi:10.1136/qshc.2008.02905.PubMedCentralPubMedCrossRef

Titel: Quality Improvement in Hospital Management of Community-Acquired Pneumonia: Focus on New Strategies and Current Challenges
verfasst von: Elizabeth A. Richey
Lauren Dudley
Stephen K. Liu
Publikationsdatum: 01.02.2014
Verlag: Springer US
Erschienen in: Current Infectious Disease Reports / Ausgabe 2/2014
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-014-0395-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen